Home

Andrew Lansley backs value-based drug pricing

By 2008-09-18T09:00:00

Pharmaceutical companies should be paid according to the benefits that their drugs bring to patients, shadow health secretary Andrew Lansley has said.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here